BibTex RIS Kaynak Göster

-

Yıl 2014, Cilt: 36 Sayı: 1, 51 - 56, 28.03.2014

Dinçer Sümer , Ayşe Yenicesu Abdullah Boztosun Fırat Çil Yasin Bıyık Ahmet Mutlu Ali Yanık

https://doi.org/10.7197/cmj.v36i1.1008002146
Cited By: 1

Öz

Aim. The objective of this study is to compare clinical and demographic data of benign and malign pathologies of endometrium and to describe risc factors for endomatrial carcinoma. Method. Eighty-eight patients which was hysterectomised in our clinic between 2006 and 2010 was included. Twenty eight of these has the diagnosis as ‘proliferative endometrium’, twenty nine as ‘hyperplasia of endometrium’, thirty-one as ‘endometrioid type of endometrial carcinoma’. Data were collected from patient files retrospectively. Results. Pregnancy and parity rate, presence of diabetes mellitus and smoking were not altered for groups. Endometrial thickness and presence of hypertension were significantly higher for carcinoma group. Endometrial carcinoma patients were generally postmenauposal and had younger menarche age. Discussion. Advanced age, early menarche, increased endometrial thickness, hypertension and postmenapouse are risk factors for endometrial carcinoma.

Anahtar Kelimeler

Endometrial carcinoma risk factors

Kaynakça

  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
  • Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu Kanser Daire Başkanlığı 20042006 Yılları Türkiye Kanser İnsidansı http://kanser.gov.tr/folders/file/8iL-2006SON.pdf
  • Kumar V, Abbas A. Robbins and Cotran patologic basis of disease eight edition Philadelphia saunders elsevier 2010; pp: 1005-65.
  • Xu WH, Xiang YB, Ruan ZX, Zheng W, Cheng JR, Dai Q, Gao YT, Shu XO. Menstrual and reproductive factors and endometrial cancer risk: Results from a population-based case-control study in urban Shanghai. Int J Cancer 2004; 108: 613Sorosky JI. Endometrial cancer. Obstet Gynecol 2008; 111: 436-47.
  • Göksedef BP, Akbayır Ö, Çorbacıoğlu A, Güraslan H, Şencan F, Erol O, Çetin A. Comparison of preoperative endometrial biopsy grade and final pathologic diagnosis in patients with endometrioid endometrial cancer. J Turkish-German Gynecol Assoc 2012; 13: 106-10.
  • Aka N, Civak LÜ, Köse G, Türkay Ü, Karayel S, Aksu Ö. Endometrial Kanser: 58 Olguda Tanı ve Tedavi Deneyimi. Türk Jinekolojik Onkoloji Dergisi 2007; 10: 16-22.
  • Tabor A, Watt HC, Wald NJ. Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding. Obstet Gynecol 2002; 99: 663-70.
  • Timmermans A, Opmeer BC, Khan KS, Bachmann LM, Epstein E, Clark TJ, Gupta JK, Bakour SH, van den Bosch T, van Doorn HC, Cameron ST, Giusa MG, Dessole S, Dijkhuizen FP, Ter Riet G, Mol BW. Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and meta-analysis. Obstet Gynecol 2010; 116: 160
  • Sorosky, Joel I. Endometrial Cancer. Obstetrıcs & Gynecology 2012; 120: 383
  • Langer RD, Pierce JJ, O'Hanlan KA, Johnson SR, Espeland MA, Trabal JF, Barnabei VM, Merino MJ, Scully RE. Transvaginal Ultrasonography Compared With Endometrial Biopsy For The Detection Of Endometrial Disease. Postmenopausal Estrogen/Progestin Interventions Trial. N Engl J Med 1997; 337: 1792Gull B, Carlsson S, Karlsson B, Ylöstalo P, Milsom I, Granberg S. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding: is it always necessary to perform an endometrial biopsy? Am J Obstet Gynecol 2000; 182: 509-15.
  • Smith-Bindman R, Kerlikowske K, Feldstein VA, Subak L, Scheidler J, Segal M, Brand R, Grady D. Endovaginal Ultrasound To Exclude Endometrial Cancer And Other Endometrial Abnormalities. Jama 1998; 280: 1510-7.
  • Granberg S, Karlsson B, Wikland M, Gull B: Uterus ve Endometriyum Hastalıklarının Transvajinal Sonografisi. In: Fleischer AC, Manning FA, Jeanty P, Romero R, (eds.) Obstetrik ve Jinekolojide Sonografi, beşinci baskı, Ulusal Tıp Kitabevi 2000; 851-68.
  • Berek SJ. Berek&novak’s Gynecology 14th edition, Philadelphia William&Wilkins, 2007.
  • Erkun E: Hormon Replasman Tedavisi ve Endometrium Kanseri. In: Ertungealp E, Seyisoğlu H, (eds.) Menopoz ve Osteoporoz, birinci baskı, Menopoz ve Osteoporoz Derneği, İstanbul, 2000; 283-6.
  • Chamlian DL, Taylor HB. Endometrial hyperplasia in young women. Obstet Gynecol 1970; 36: 659-66.
  • Parazzini F, Negri E, La Vecchia C, Benzi G, Chiaffarino F, Polatti A, Francheschi S. Role of reproductive factors on the risk of endometrial cancer. Int J Cancer 1998; 76: 784-6.
  • Parazzini F, La Vecchia C, Negri E, Fedele L, Balotta F. Reproductive factors and risk of endometrial cancer. Am J Obstet Gynecol 1991; 164: 522-7.
  • McPherson CP, Sellers TA, Potter JD, Bostick RM, Folsom AR. Reproductive factors and risk of endometrial cancer. The Iowa Women's Health Study. Am J Epidemiol 1996; 143: 1195-202.
  • Lİchen ML, Lund E. Childbearing and mortality from cancer of the corpus uteri. Acta Obstet Gynecol Scand 1997; 76: 373-7.
  • Gerber J, Sozański L, Suchocki S. The risk factors of endometrial cancer. Ginekol Pol 2001; 72(12A): 1418-22.
  • Noto H, Osame K, Sasazuki T, Noda M. Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan. J Diabetes Complications 2010; 24: 345-53.
  • Friberg E, Orsini N, Mantzoros CS, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 2007; 50: 1365-74.
  • Nicholas Z, Hu N, Ying J, Soisson P, Dodson M, Gaffney DK. Impact of Comorbid Conditions on Survival in Endometrial Cancer. Am J Clin Oncol 2012 Dec 13
  • Brinton LA, Lacey JV Jr, Devesa SS: Epidemiology of uterine corpus cancer. In Gershenson DM, McGuire WP, Gore M, Quinn MA, Thomas G. (eds): Gynecologic Cancer: Controversies in Management. New York, Churchill Livingstone, 2004; pp: 190.
  • Viswanathan AN1, Feskanich D, De Vivo I, Hunter DJ, Barbieri RL, Rosner B, Colditz GA, Hankinson SE. Smoking and the risk of endometrial cancer: Results from the Nurses' Health Study. Int J Cancer 2005; 114: 996-1001.

Benign ve malign endometriyal patolojilerin klinik ve demografik özelliklerinin karşılaştırılması

Yıl 2014, Cilt: 36 Sayı: 1, 51 - 56, 28.03.2014

Dinçer Sümer , Ayşe Yenicesu Abdullah Boztosun Fırat Çil Yasin Bıyık Ahmet Mutlu Ali Yanık

https://doi.org/10.7197/cmj.v36i1.1008002146
Cited By: 1

Öz

Özet

Amaç. Bu çalışma endometriyum kanseri ve benign endometriyal patolojilerin klinik ve demografik verilerini karşılaştırmayı ve endometriyum kanseri için risk faktörlerini belirlemeyi amaçlamaktadır. Yöntem. Kliniğimizde 2006-2010 yılları arasında endometrioid tip endometrial karsinom tanısı almış 31, endometriyal hiperplazi tanısı almış 29 ve proliferatif endometriyum tanısı almış 28 olmak üzere toplam 88 histerektomi olgusu çalışmaya dahil edildi. Olguların demografik ve takip bilgileri klinik dosyalarından elde edildi. Bulgular. Gebelik ve parite sayısı, diyabet varlığı ve sigara kullanımı arasında fark bulunamazken; ortalama yaş, endometriyal kalınlık değeri, menarş yaşı, postmenapozal olmak ve hipertansiyon varlığı endometriyum kanseri grubunda farklı bulunmuştur. Sonuç. Endometriyum kanseri hastaları daha erken yaşta menarş görmektedir ve çoğu postmenapozaldir İleri yaş, artmış endometriyal kalınlık ve hipertansiyon endometriyum kanseri için diğer risk faktörleridir.

Anahtar sözcükler: Endometriyum kanseri, risk faktörleri

 

Abstract

Aim. The objective of this study is to compare clinical and demographic data of benign and malign pathologies of endometrium and to describe risc factors for endomatrial carcinoma. Method. Eighty-eight patients which was hysterectomised in our clinic between 2006 and 2010 was included. Twenty eight of these has the diagnosis as ‘proliferative endometrium’, twenty nine as ‘hyperplasia of endometrium’, thirty-one as ‘endometrioid type of endometrial carcinoma’. Data were collected from patient files retrospectively. Results. Pregnancy and parity rate, presence of diabetes mellitus and smoking were not altered for groups. Endometrial thickness and presence of hypertension were significantly higher for carcinoma group. Endometrial carcinoma patients were generally postmenauposal and had younger menarche age. Discussion. Advanced age, early menarche, increased endometrial thickness, hypertension and postmenapouse are risk factors for endometrial carcinoma.

Keywords: Endometrial carcinoma, risk factors

Anahtar Kelimeler

Endometriyum kanseri risk faktörleri

Kaynakça

  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
  • Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu Kanser Daire Başkanlığı 20042006 Yılları Türkiye Kanser İnsidansı http://kanser.gov.tr/folders/file/8iL-2006SON.pdf
  • Kumar V, Abbas A. Robbins and Cotran patologic basis of disease eight edition Philadelphia saunders elsevier 2010; pp: 1005-65.
  • Xu WH, Xiang YB, Ruan ZX, Zheng W, Cheng JR, Dai Q, Gao YT, Shu XO. Menstrual and reproductive factors and endometrial cancer risk: Results from a population-based case-control study in urban Shanghai. Int J Cancer 2004; 108: 613Sorosky JI. Endometrial cancer. Obstet Gynecol 2008; 111: 436-47.
  • Göksedef BP, Akbayır Ö, Çorbacıoğlu A, Güraslan H, Şencan F, Erol O, Çetin A. Comparison of preoperative endometrial biopsy grade and final pathologic diagnosis in patients with endometrioid endometrial cancer. J Turkish-German Gynecol Assoc 2012; 13: 106-10.
  • Aka N, Civak LÜ, Köse G, Türkay Ü, Karayel S, Aksu Ö. Endometrial Kanser: 58 Olguda Tanı ve Tedavi Deneyimi. Türk Jinekolojik Onkoloji Dergisi 2007; 10: 16-22.
  • Tabor A, Watt HC, Wald NJ. Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding. Obstet Gynecol 2002; 99: 663-70.
  • Timmermans A, Opmeer BC, Khan KS, Bachmann LM, Epstein E, Clark TJ, Gupta JK, Bakour SH, van den Bosch T, van Doorn HC, Cameron ST, Giusa MG, Dessole S, Dijkhuizen FP, Ter Riet G, Mol BW. Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and meta-analysis. Obstet Gynecol 2010; 116: 160
  • Sorosky, Joel I. Endometrial Cancer. Obstetrıcs & Gynecology 2012; 120: 383
  • Langer RD, Pierce JJ, O'Hanlan KA, Johnson SR, Espeland MA, Trabal JF, Barnabei VM, Merino MJ, Scully RE. Transvaginal Ultrasonography Compared With Endometrial Biopsy For The Detection Of Endometrial Disease. Postmenopausal Estrogen/Progestin Interventions Trial. N Engl J Med 1997; 337: 1792Gull B, Carlsson S, Karlsson B, Ylöstalo P, Milsom I, Granberg S. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding: is it always necessary to perform an endometrial biopsy? Am J Obstet Gynecol 2000; 182: 509-15.
  • Smith-Bindman R, Kerlikowske K, Feldstein VA, Subak L, Scheidler J, Segal M, Brand R, Grady D. Endovaginal Ultrasound To Exclude Endometrial Cancer And Other Endometrial Abnormalities. Jama 1998; 280: 1510-7.
  • Granberg S, Karlsson B, Wikland M, Gull B: Uterus ve Endometriyum Hastalıklarının Transvajinal Sonografisi. In: Fleischer AC, Manning FA, Jeanty P, Romero R, (eds.) Obstetrik ve Jinekolojide Sonografi, beşinci baskı, Ulusal Tıp Kitabevi 2000; 851-68.
  • Berek SJ. Berek&novak’s Gynecology 14th edition, Philadelphia William&Wilkins, 2007.
  • Erkun E: Hormon Replasman Tedavisi ve Endometrium Kanseri. In: Ertungealp E, Seyisoğlu H, (eds.) Menopoz ve Osteoporoz, birinci baskı, Menopoz ve Osteoporoz Derneği, İstanbul, 2000; 283-6.
  • Chamlian DL, Taylor HB. Endometrial hyperplasia in young women. Obstet Gynecol 1970; 36: 659-66.
  • Parazzini F, Negri E, La Vecchia C, Benzi G, Chiaffarino F, Polatti A, Francheschi S. Role of reproductive factors on the risk of endometrial cancer. Int J Cancer 1998; 76: 784-6.
  • Parazzini F, La Vecchia C, Negri E, Fedele L, Balotta F. Reproductive factors and risk of endometrial cancer. Am J Obstet Gynecol 1991; 164: 522-7.
  • McPherson CP, Sellers TA, Potter JD, Bostick RM, Folsom AR. Reproductive factors and risk of endometrial cancer. The Iowa Women's Health Study. Am J Epidemiol 1996; 143: 1195-202.
  • Lİchen ML, Lund E. Childbearing and mortality from cancer of the corpus uteri. Acta Obstet Gynecol Scand 1997; 76: 373-7.
  • Gerber J, Sozański L, Suchocki S. The risk factors of endometrial cancer. Ginekol Pol 2001; 72(12A): 1418-22.
  • Noto H, Osame K, Sasazuki T, Noda M. Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan. J Diabetes Complications 2010; 24: 345-53.
  • Friberg E, Orsini N, Mantzoros CS, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 2007; 50: 1365-74.
  • Nicholas Z, Hu N, Ying J, Soisson P, Dodson M, Gaffney DK. Impact of Comorbid Conditions on Survival in Endometrial Cancer. Am J Clin Oncol 2012 Dec 13
  • Brinton LA, Lacey JV Jr, Devesa SS: Epidemiology of uterine corpus cancer. In Gershenson DM, McGuire WP, Gore M, Quinn MA, Thomas G. (eds): Gynecologic Cancer: Controversies in Management. New York, Churchill Livingstone, 2004; pp: 190.
  • Viswanathan AN1, Feskanich D, De Vivo I, Hunter DJ, Barbieri RL, Rosner B, Colditz GA, Hankinson SE. Smoking and the risk of endometrial cancer: Results from the Nurses' Health Study. Int J Cancer 2005; 114: 996-1001.
Toplam 25 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Cerrahi Tıp Bilimleri Araştırma Yazıları
Yazarlar

Dinçer Sümer

Ayşe Yenicesu

Abdullah Boztosun

Fırat Çil

Yasin Bıyık

Ahmet Mutlu

Ali Yanık

Yayımlanma Tarihi 28 Mart 2014
Yayımlandığı Sayı Yıl 2014Cilt: 36 Sayı: 1

Kaynak Göster

AMA Sümer D, Yenicesu A, Boztosun A, Çil F, Bıyık Y, Mutlu A, Yanık A. Benign ve malign endometriyal patolojilerin klinik ve demografik özelliklerinin karşılaştırılması. CMJ. Mart 2014;36(1):51-56. doi:10.7197/cmj.v36i1.1008002146

Cited By

KİNAZOLİN TÜREVİ BİLEŞİKLERİN OLASI SİTOTOKSİK ETKİLERİNİN ENDOMETRİYUM KANSER HÜCRELERİNDE ARAŞTIRILMASI
Sağlık Bilimleri Dergisi
Ayşe Eken
https://doi.org/10.34108/eujhs.503642